Alston & Bird assisted Getinge AB in its pending $680 million acquisition of Atrium Medical Corporation.  The transaction is expected to further expand the cardiovascular medical device presence of Getinge, a global healthcare and life sciences company based in Sweden.  The transaction is subject to regulatory approvals and other customary conditions, but is expected to close in the fourth quarter of 2011.

Atrium’s core product lines include cardio-thoracic drainage products, vascular grafts, balloon expandable covered stents, thrombus management catheters and biosurgery products.  Atrium also has a strong pipeline of developmental products, including products based on its know-how and extensive expertise in the deployment of ePTFE in medical-technical applications. 

Getinge has previously grown its presence in the cardiovascular medical device market with the $750 million acquisition of Boston Scientific Corp.’s cardiac and vascular surgery units in 2008 and the $865 million acquisition of publicly-traded Datascope Corp. in 2009.  Alston & Bird also assisted Getinge on those transactions. 

Getinge was counseled on the Atrium deal by an interdisciplinary team from Alston & Bird led by Steve Pottle and Perry Smith, and including Sam Kaywood, Don Segal, George Taulbee, Mike Stevens, Blake MacKay, Trent Kirk, Dawnmarie Matlock, Christina Rogers, Valarie Williams, Julie Tibbets, Kim Fogarty, Brett Coburn, Matthew Kent, Brian Harvel, Jennifer Lyle and Molly Jones.